Neuralink plans high-volume brain chip production in 2026, aiming automated implants and expanded human trials.
Browsing: human trials
Neuralink aims to implant brain chips in 20,000 people annually by 2031, advancing neurotechnology for communication, vision restoration, and treatment of neurological disorders.
A major Chinese brain-computer interface (BCI) initiative is gaining momentum, with plans to implant its Beinao No.1 brain chip in 13 patients by the end of this year